Silencing of TGM2 reverses epithelial to mesenchymal transition and modulates the chemosensitivity of breast cancer to docetaxel

Author：      

Publisher： Spandidos Publications

E-ISSN： 1792-1015|10|4|1413-1418

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.10, Iss.4, 2015-01, pp. : 1413-1418

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epithelial-Mesenchymal Transition-A Hallmark of Breast Cancer Metastasis

By Wang Yifan   Zhou Binhua P.  

Cancer Hallmarks, Vol. 1, Iss. 1, 2013-03 ,pp. : 38-49

American Scientific Publishers

Access to resources Recommend Favorite

Silencing Notch-1 induces apoptosis and increases the chemosensitivity of prostate cancer cells to docetaxel through Bcl-2 and Bax

By Ye Qi-Fa   Zhang Yi-Chuan   Peng Xiao-Qing   Long Zhi   Ming Ying-Zi   He Le-Ye  

Oncology Letters, Vol. 3, Iss. 4, 2012-04 ,pp. : 879-884

Spandidos Publications

Access to resources Recommend Favorite

STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits

By        

International Journal of Oncology, Vol. 44, Iss. 2, 2014-01 ,pp. : 403-411

Spandidos Publications

Access to resources Recommend Favorite

Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway

By      

Oncology Reports, Vol. 29, Iss. 6, 2013-01 ,pp. : 2401-2407

Spandidos Publications

Access to resources Recommend Favorite

Mesenchymal-epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer

By Gunasinghe N.  

Cancer and Metastasis Reviews, Vol. 31, Iss. 3-4, 2012-12 ,pp. : 469-478

Springer Publishing Company

Access to resources Recommend Favorite